| Estimated Vaccination Coverage*,† With Selected Vaccines Among Adolescents Aged 13-17 Years§, by State and Selected Local Areas -- National Immunization Survey-Teen, United States, 2008 |
| > 1 Td or Tdap¶ % (95% CI) | >1 Tdap** % (95% CI) | >1 MCV4†† % (95% CI) | >1 HPV4§§ % (95% CI) | > 3 doses HPV4 % (95% CI) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| US National | 72.2 (70.8-73.4) | 40.8 (39.3-42.2) | 41.8 (40.3-43.2) | 37.2 (35.1-39.3) | 17.9 (16.3-19.6) | |||||
| Alabama | 70.1 (64.6-75.0) | 44.0 (38.4-49.8) | 29.9 (24.8-35.5) | 32.8 (25.5-41.1) | 13.2 (8.8-19.3) | |||||
| Alaska | 68.3 (62.2-73.7) | 42.1 (36.2-48.3) | 30.5 (25.1-36.5) | 38.8 (30.6-47.8) | 21.0 (14.7-29.0) | |||||
| Arizona | 74.0 (66.4-80.4) | 53.8 (46.4-60.9) | 51.5 (44.2-58.7) | 50.5 (40.3-60.7) | 20.8 (13.8-30.1) | |||||
| Arkansas | 46.1 (40.4-52.0) | 23.8 (19.2-29.1) | 14.5 (10.8-19.1) | 22.4 (16.2-30.2) | NA | |||||
| California | 71.3 (64.1-77.5) | 43.7 (36.4-51.3) | 48.0 (40.6-55.5) | 46.6 (36.1-57.5) | 22.1 (14.2-32.8) | |||||
| Colorado | 77.4 (70.9-82.9) | 63.0 (56.0-69.5) | 32.4 (26.3-39.1) | 33.5 (25.6-42.6) | 19.0 (12.7-27.4) | |||||
| Connecticut | 79.8 (73.2-85.0) | 45.4 (38.5-52.5) | 45.2 (38.2-52.4) | 45.0 (35.6-54.8) | 23.3 (16.4-32.0) | |||||
| Delaware | 78.6 (72.9-83.3) | 43.1 (36.9-49.6) | 58.6 (52.1-64.7) | 46.8 (37.9-56.0) | 26.1 (18.8-34.9) | |||||
| District of Columbia | 84.7 (79.9-88.6) | 32.7 (27.1-38.9) | 58.1 (51.7-64.2) | 38.7 (30.0-48.3) | 12.4 (7.7-19.3) | |||||
| Florida | 79.4 (70.3-86.2) | 29.0 (22.6-36.2) | 33.6 (26.7-41.2) | 36.7 (26.8-48.0) | 20.2 (13.3-29.6) | |||||
| Georgia | 70.9 (64.5-76.5) | 37.8 (31.6-44.4) | 41.6 (35.2-48.3) | 18.5 (13.0-25.6) | 8.1 (5.0-12.9) | |||||
| Hawaii | 71.6 (65.7-76.9) | 32.0 (26.5-38.0) | 44.1 (38.1-50.3) | 40.2 (32.3-48.6) | 18.7 (13.1-25.9) | |||||
| Idaho | 51.3 (44.5-58.0) | 31.7 (25.7-38.3) | 29.9 (24.1-36.5) | 28.4 (20.5-38.0) | 8.0 (4.4-14.1) | |||||
| Illinois | 72.9 (67.7-77.6) | 45.4 (39.9-51.0) | 41.9 (36.5-47.6) | 27.0 (20.8-34.2) | 12.8 (8.5-18.9) | |||||
| IL-City of Chicago | 71.8 (65.6-77.3) | 44.2 (38.0-50.5) | 41.1 (35.1-47.5) | 28.6 (20.8-37.9) | 11.2 (6.5-18.6) | |||||
| IL-Rest of State | 73.2 (66.7-78.8) | 45.7 (39.0-52.6) | 42.1 (35.5-49.1) | 26.6 (19.2-35.6) | 13.3 (8.2-20.9) | |||||
| Indiana | 53.6 (47.4-59.7) | 31.2 (26.1-36.7) | 31.8 (26.5-37.8) | 26.1 (19.8-33.6) | 11.6 (7.4-17.6) | |||||
| Iowa | 65.9 (59.4-71.8) | 43.5 (37.4-49.9) | 31.9 (26.4-38.0) | 41.9 (32.6-51.9) | 26.8 (18.7-36.7) | |||||
| Kansas | 69.9 (63.4-75.6) | 46.8 (40.1-53.7) | 25.6 (20.0-32.3) | 30.1 (21.8-40.0) | 15.6 (9.1-25.3) | |||||
| Kentucky | 82.0 (76.2-86.6) | 28.1 (22.6-34.3) | 30.9 (25.3-37.0) | 26.3 (18.8-35.4) | 12.7 (8.1-19.4) | |||||
| Louisiana | 74.9 (69.3-79.8) | 35.3 (29.8-41.3) | 53.6 (47.5-59.6) | 36.6 (28.3-45.6) | 16.5 (11.0-24.1) | |||||
| Maine | 75.0 (69.1-80.1) | 43.0 (36.9-49.3) | 35.6 (29.9-41.7) | 40.3 (32.2-49.0) | 21.4 (14.9-29.8) | |||||
| Maryland | 79.0 (73.0-83.9) | 37.9 (32.2-44.0) | 54.6 (48.2-60.7) | 41.1 (32.4-50.5) | 14.2 (9.7-20.5) | |||||
| Massachusetts | 94.4 (90.5-96.8) | 43.3 (37.1-49.8) | 55.9 (49.4-62.2) | 53.3 (43.8-62.6) | 29.1 (21.7-37.8) | |||||
| Michigan | 69.9 (63.9-75.3) | 33.6 (27.9-39.8) | 39.9 (33.9-46.2) | 32.3 (23.8-42.1) | 13.5 (8.5-20.7) | |||||
| Minnesota | 88.7 (84.2-92.0) | 40.7 (34.8-46.8) | 38.9 (33.0-45.1) | 33.6 (26.4-41.6) | 14.7 (10.1-20.7) | |||||
| Mississippi | 28.7 (23.7-34.3) | 19.6 (15.3-24.7) | 14.8 (10.9-19.8) | 15.8 (10.6-23.0) | NA | |||||
| Missouri | 67.9 (61.9-73.4) | 44.1 (38.1-50.3) | 35.3 (29.6-41.5) | 31.6 (23.8-40.7) | 15.1 (9.8-22.6) | |||||
| Montana | 69.1 (62.6-74.8) | 44.2 (37.8-50.7) | 17.8 (13.1-23.6) | 17.8 (12.0-25.5) | 8.6 (4.8-15.1) | |||||
| Nebraska | 71.5 (65.6-76.7) | 42.2 (36.5-48.0) | 37.2 (31.8-42.9) | 29.5 (23.0-37.0) | 17.5 (12.4-24.3) | |||||
| Nevada | 69.0 (61.6-75.5) | 45.9 (38.6-53.2) | 29.6 (23.3-36.9) | 30.0 (21.2-40.5) | NA | |||||
| New Hampshire | 84.2 (77.1-89.4) | 53.1 (45.8-60.2) | 54.6 (47.3-61.7) | 54.4 (44.3-64.1) | 23.2 (15.3-33.5) | |||||
| New Jersey | 78.1 (72.4-83.0) | 43.0 (37.0-49.3) | 60.6 (54.2-66.6) | 43.0 (34.3-52.1) | 20.4 (14.2-28.3) | |||||
| New Mexico | 75.1 (68.8-80.5) | 50.4 (43.7-57.0) | 39.6 (33.3-46.3) | 48.3 (38.4-58.4) | 23.2 (15.4-33.4) | |||||
| New York | 85.5 (81.9-88.5) | 53.8 (48.9-58.6) | 56.0 (51.1-60.8) | 50.2 (43.1-57.3) | 29.2 (22.9-36.4) | |||||
| NY-City of New York | 85.4 (80.0-89.5) | 49.4 (42.3-56.5) | 53.5 (46.4-60.5) | 48.3 (38.0-58.7) | 24.3 (16.2-34.9) | |||||
| NY-Rest of State | 85.6 (80.6-89.5) | 56.8 (50.1-63.2) | 57.7 (51.1-64.0) | 51.5 (41.9-61.0) | 32.5 (23.9-42.5) | |||||
| North Carolina | 63.6 (56.9-69.8) | 28.0 (22.8-33.8) | 30.7 (25.2-36.9) | 34.4 (26.3-43.6) | 17.8 (12.2-25.3) | |||||
| North Dakota | 75.0 (69.4-79.9) | 47.8 (42.2-53.5) | 47.4 (41.7-53.1) | 28.7 (21.9-36.7) | 15.9 (10.8-22.8) | |||||
| Ohio | 57.8 (51.2-64.1) | 30.6 (25.2-36.7) | 37.7 (31.7-44.1) | 29.1 (21.6-37.9) | 15.6 (10.0-23.5) | |||||
| Oklahoma | 59.5 (53.1-65.5) | 28.6 (23.3-34.5) | 25.1 (20.0-30.9) | 35.5 (27.3-44.7) | 16.6 (10.9-24.4) | |||||
| Oregon | 64.1 (56.6-71.0) | 38.9 (32.2-45.9) | 29.6 (23.7-36.3) | 34.8 (25.6-45.3) | 14.3 (8.7-22.4) | |||||
| Pennsylvania | 82.0 (77.1-86.0) | 51.2 (45.8-56.7) | 59.7 (54.2-65.1) | 46.1 (38.7-53.7) | 25.7 (19.5-33.0) | |||||
| PA-Philadelphia County | 79.7 (73.9-84.5) | 48.6 (42.4-54.8) | 66.3 (60.1-72.1) | 51.8 (43.3-60.3) | 20.7 (14.1-29.3) | |||||
| PA-Rest of State | 82.3 (76.7-86.8) | 51.7 (45.4-57.9) | 58.7 (52.4-64.8) | 45.2 (36.8-53.9) | 26.5 (19.5-34.9) | |||||
| Rhode Island | 91.5 (86.5-94.8) | 41.6 (34.7-48.9) | 62.6 (55.3-69.5) | 54.7 (44.2-64.8) | 31.4 (23.2-40.9) | |||||
| South Carolina | 53.7 (47.8-59.5) | 27.3 (22.4-32.9) | 25.1 (20.1-30.8) | 18.7 (13.2-25.9) | 13.8 (9.0-20.7) | |||||
| South Dakota | 45.3 (39.3-51.4) | 19.3 (15.1-24.4) | 14.0 (10.3-18.9) | 45.9 (37.9-54.1) | 34.2 (26.9-42.4) | |||||
| Tennessee | 50.3 (44.0-56.6) | 34.3 (28.5-40.5) | 36.5 (30.7-42.8) | 29.6 (21.5-39.3) | 13.0 (7.9-20.9) | |||||
| Texas | 79.3 (73.4-84.3) | 40.8 (34.0-48.1) | 37.4 (30.9-44.3) | 31.6 (23.2-41.5) | 9.7 (5.8-15.6) | |||||
| TX-Bexar County | 77.7 (71.0-83.2) | 42.0 (35.0-49.3) | 43.2 (36.2-50.5) | 40.7 (30.6-51.7) | 20.2 (12.9-30.2) | |||||
| TX-City of Houston | 73.0 (63.8-80.6) | 42.6 (34.0-51.8) | 51.9 (42.9-60.7) | 30.2 (20.3-42.4) | 13.8 (7.9-22.9) | |||||
| TX-Rest of State | 80.1 (73.0-85.6) | 40.6 (32.7-49.0) | 35.6 (28.2-43.7) | 31.1 (21.4-42.7) | NA | |||||
| Utah | 62.7 (54.9-69.9) | 46.8 (39.4-54.3) | 31.3 (24.9-38.6) | 17.1 (10.3-27.2) | NA | |||||
| Vermont | 79.8 (73.7-84.8) | 49.2 (42.5-55.9) | 20.0 (15.2-25.8) | 50.4 (40.9-59.8) | 25.8 (18.2-35.2) | |||||
| Virginia | 70.3 (63.6-76.3) | 49.1 (42.1-56.1) | 43.8 (37.1-50.8) | 40.6 (31.9-50.0) | 21.2 (14.7-29.6) | |||||
| Washington | 64.2 (57.4-70.5) | 34.7 (28.7-41.2) | 40.0 (33.5-46.8) | 46.5 (37.1-56.1) | 23.8 (16.1-33.7) | |||||
| West Virginia | 44.7 (38.3-51.2) | 24.1 (19.1-29.9) | 30.2 (24.6-36.4) | 33.6 (25.7-42.6) | 17.1 (11.3-25.1) | |||||
| Wisconsin | 75.4 (69.1-80.8) | 53.8 (47.1-60.4) | 52.2 (45.5-58.9) | 47.0 (37.0-57.1) | 22.6 (14.9-32.7) | |||||
| Wyoming | 79.1 (73.1-84.1) | 28.3 (23.0-34.3) | 32.8 (27.2-39.0) | 36.2 (27.7-45.7) | 19.8 (13.5-28.2) |
| * Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6. | ||||||||||||
| †Estimate may be unreliable; (CI width)>20. | ||||||||||||
| §Adolescents in the 2008 NIS-Teen were born during January 1990 - February 1996. Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records. | ||||||||||||
| ¶ Includes > 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years. | ||||||||||||
| ** Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years. | ||||||||||||
| †† Includes percentages receiving meningococcal conjugate vaccine (MCV4) and meningococcal -unknown type vaccine. | ||||||||||||
| §§ Quadrivalent human papillomavirus vaccine. Percentages reported among females only (n=8,607); HPV4 vaccine is not recommended for males. | ||||||||||||
| tab01_iap | ||||||||||